What exactly is a peptide?
A peptide is a short chain of amino acids, usually somewhere between 2 and 50, linked by chemical bonds. String enough of them together and fold the chain into a shape, and you have a protein.
Your body makes thousands of peptides on its own. Insulin, which tells your cells to take in sugar, is a peptide. So is oxytocin, and so are the hormones that tell your brain you've eaten enough. Most peptides work as messengers: they carry one specific instruction from one place in the body to another.
"Peptide therapy" means using natural peptides, or lab-designed versions of them, to send those instructions on purpose. That precision is the appeal. It's also why the word "peptide" on its own tells you almost nothing about whether a product works or is safe. Dozens of peptides are well-studied, FDA-approved medicines. Others are sold online with little more than mouse studies behind them.
How peptides work in the body.
Think of a peptide as a key and a receptor as a lock. When the right key fits, the cell gets a message and responds.
Because the body breaks peptides down quickly in the gut, most therapeutic peptides are given as small injections under the skin. A few come as nasal sprays, creams, or specially engineered pills. How long a peptide lasts in the body, called its half-life, varies from minutes to about a week, which is why some are taken daily and others weekly.
Not all peptides are equal in the eyes of the law.
Before you read about any single peptide, it helps to know which of three categories it falls into. This one distinction explains most of the confusion online.
FDA-approved drugs
Went through full clinical trials and FDA review for a specific use. Made by a licensed manufacturer to strict standards.
- Examples
- Semaglutide, tirzepatide, tesamorelin, and bremelanotide.
- How you get it
- A prescription, filled at any pharmacy.
Compounded
Prepared by a licensed pharmacy for one patient's prescription. Legal for certain ingredients, but the final product isn't FDA-reviewed for safety or effectiveness.
- Examples
- Sermorelin, plus others depending on current FDA lists.
- How you get it
- A prescription from a clinician, prepared by a compounding pharmacy.
"Research use only"
Sold online with a label saying it's not for humans. No prescription, no pharmacy oversight, and quality varies widely from vial to vial.
- Examples
- Most peptides sold directly to consumers online.
- How you get it
- A direct online purchase, with no prescription. Not intended for human use.
How we rate the evidence.
Every peptide on PeptidalWave gets one of four ratings, based on the strongest human evidence that exists for it. The rating is about the science, not about whether we think you should use it.
FDA-approved
Proven in large human trials and approved for at least one use.
Clinical
Meaningful human trials exist, but it isn't approved for the use most people buy it for.
Early human
Small or short human studies. Promising, far from proven.
Preclinical
Mostly animal or cell studies. Human benefit and safety are unknown.
The peptide index.
Filter by what you're curious about or by how strong the evidence is. Select any peptide to jump to its full profile.
Semaglutide
Reduces appetite and improves blood sugar control. Taken weekly.
Tirzepatide
Acts on two appetite and metabolism pathways at once.
Tesamorelin
Raises growth hormone to reduce deep abdominal fat.
Bremelanotide (PT-141)
Acts on the brain's desire pathways rather than blood flow.
Sermorelin
Prompts the pituitary to release growth hormone in natural pulses.
CJC-1295 / Ipamorelin
A popular combination meant to amplify growth hormone release.
GHK-Cu
Studied mostly in skin care for collagen and repair.
BPC-157
Widely hyped for healing. Human data is still very thin.
TB-500
Marketed for tissue repair. Banned in competitive sport.
Peptide profiles.
What each peptide is, what the research shows, where it stands with regulators, and who should steer clear. We don't publish dosing; that belongs between you and a licensed clinician.
Semaglutide
What it is
A lab-made version of GLP-1, a hormone your gut releases after eating, engineered to last about a week in the body.
How it works
Signals fullness to the brain, slows how quickly the stomach empties, and helps the pancreas release insulin when blood sugar rises.
What the research shows
Large, long-term human trials show substantial average weight loss and improved blood sugar control, and it has been shown to lower cardiovascular risk in certain patients. It is one of the most studied peptides in the world.
Regulatory status
FDA-approved for type 2 diabetes and chronic weight management. During the national shortage, compounding was widely allowed; after the FDA declared the shortage over in 2025, compounding pharmacies were largely required to stop making copies.
Common side effects
Nausea, constipation or diarrhea, and reduced appetite, usually worst when the dose is increased.
Who should avoid it
People with a personal or family history of medullary thyroid cancer or MEN2, and those who are pregnant. A history of pancreatitis requires careful medical review.
Tirzepatide
What it is
A single molecule that activates two gut-hormone receptors, GIP and GLP-1, given as a weekly injection.
How it works
Combines GLP-1's effects on fullness and insulin with GIP's effects on how the body stores and uses energy.
What the research shows
Large clinical trials show average weight loss that is generally greater than with single-pathway GLP-1 drugs, along with improvements in blood sugar and other metabolic markers.
Regulatory status
FDA-approved for type 2 diabetes, chronic weight management, and obstructive sleep apnea in adults with obesity. The FDA declared its shortage resolved in late 2024, which ended most large-scale compounding.
Common side effects
Nausea, diarrhea, vomiting, and constipation, most often during dose increases.
Who should avoid it
People with a personal or family history of medullary thyroid cancer or MEN2, and those who are pregnant. A history of pancreatitis requires careful medical review.
Tesamorelin
What it is
A stabilized version of the hormone that tells your pituitary gland to release growth hormone.
How it works
Raises your own growth hormone and IGF-1 levels, which helps the body break down visceral fat, the deep fat around abdominal organs.
What the research shows
Randomized trials show meaningful reductions in visceral fat in people with HIV-associated lipodystrophy. Evidence for other uses, like general fat loss or anti-aging, is much more limited.
Regulatory status
FDA-approved only for reducing excess abdominal fat in adults with HIV-associated lipodystrophy. Any other use is off-label.
Common side effects
Injection-site reactions, joint pain, swelling, and possible increases in blood sugar.
Who should avoid it
People who are pregnant, have an active cancer, or have pituitary or hypothalamic disorders. People with diabetes need close monitoring.
Replace this box with your ad code or a sponsor banner
Bremelanotide (PT-141)
What it is
A peptide originally developed from research on tanning compounds, later found to affect sexual desire.
How it works
Activates melanocortin receptors in the brain involved in arousal. Unlike ED medications, it doesn't work mainly through blood flow.
What the research shows
Phase 3 trials in premenopausal women with low sexual desire showed modest but statistically significant improvements in desire and related distress. Evidence in men is more limited.
Regulatory status
FDA-approved in 2019 as an as-needed injection for acquired, generalized hypoactive sexual desire disorder in premenopausal women. Use in men is off-label.
Common side effects
Nausea (common, especially with the first doses), flushing, headache, and a temporary rise in blood pressure.
Who should avoid it
People with uncontrolled high blood pressure or known cardiovascular disease.
Sermorelin
What it is
A copy of the first 29 amino acids of your natural growth hormone-releasing hormone, which is the part that does the work.
How it works
Prompts the pituitary to release growth hormone in its normal pulses, rather than replacing growth hormone directly.
What the research shows
It was studied and approved for diagnosing and treating growth hormone deficiency in children. Evidence for adult uses like energy, sleep, or body composition comes from small studies and is not conclusive.
Regulatory status
Previously FDA-approved; the brand product was discontinued in 2008, which the manufacturer attributed to business reasons rather than safety. Today it is available through compounding pharmacies with a prescription.
Common side effects
Injection-site reactions, flushing, headache, and dizziness.
Who should avoid it
People who are pregnant or have an active cancer. Untreated thyroid problems should be addressed first.
CJC-1295 / Ipamorelin
What it is
Two separate peptides commonly sold together. CJC-1295 is a long-acting GHRH analog; ipamorelin mimics ghrelin to trigger growth hormone release.
How it works
One amplifies the signal to release growth hormone, and the other triggers the release itself, aiming for a stronger combined pulse.
What the research shows
Small early human studies show each can raise growth hormone and IGF-1 levels. There are no large trials showing the combination improves muscle, fat loss, sleep, or longevity, and pharmaceutical development of both was discontinued.
Regulatory status
Not FDA-approved for any use. Their compounding status shifted during 2026's FDA policy changes, and reports differ on where each now stands. We're tracking it and will update this profile when the FDA publishes a clear answer.
Reported side effects
Injection-site reactions, water retention, flushing, increased hunger, and tingling. Long-term effects are unknown.
Who should avoid it
People who are pregnant, have an active or past cancer, or have diabetes or blood sugar problems without medical supervision.
GHK-Cu
What it is
A three-amino-acid peptide bound to copper. Natural levels decline with age. It's a common ingredient in skin care products.
How it works
Thought to support collagen and elastin production and the skin's own repair processes, partly by delivering copper to tissues.
What the research shows
Small human studies of topical products suggest improvements in skin firmness, fine lines, and texture. Evidence for injectable use, or for hair regrowth, is mostly from lab and animal research.
Regulatory status
Widely sold in cosmetics. Injectable GHK-Cu was removed from the FDA's restricted compounding list in April 2026 and is scheduled for advisory committee review. It is not FDA-approved as a drug.
Reported side effects
Topical: mild irritation. Injectable: injection-site reactions; long-term safety is not established.
Who should avoid it
People with copper sensitivity or Wilson's disease, and those who are pregnant or breastfeeding (for injectable use).
BPC-157
What it is
A lab-made 15-amino-acid peptide based on a protein fragment found in the stomach. Its name stands for "body protection compound."
How it's thought to work
Animal studies suggest it may support blood vessel growth and tissue healing in tendons, muscle, and the gut. How it works in people is not established.
What the research shows
There are hundreds of animal studies but very few published human studies, and those are all small. FDA scientists have cited the lack of human clinical data as a major concern. Online popularity far outpaces the evidence.
Regulatory status
Not FDA-approved. Removed from the FDA's restricted compounding list in April 2026. In July 2026, an FDA advisory committee voted to recommend it for the list of substances pharmacies may compound, against the advice of FDA staff. The FDA's final decision is pending.
Reported side effects
Largely unknown in humans because so little human research exists. Product quality in the online market varies widely.
Who should avoid it
People who are pregnant, have an active or past cancer (because of its possible effect on blood vessel growth), and competitive athletes subject to drug testing.
TB-500
What it is
A short synthetic piece of thymosin beta-4, a protein involved in cell movement and wound repair.
How it's thought to work
Animal and lab studies suggest it may help cells migrate to injured areas and support new blood vessel formation.
What the research shows
The full thymosin beta-4 protein has been studied in some human trials for wound and eye healing. The TB-500 fragment sold online has essentially no published human research of its own.
Regulatory status
Not FDA-approved. Removed from the FDA's restricted compounding list in April 2026; an FDA advisory committee recommended it for the compounding list in July 2026. Final FDA action is pending. It is prohibited by the World Anti-Doping Agency.
Reported side effects
Not well characterized in humans. Reports include fatigue, headache, and injection-site reactions.
Who should avoid it
People who are pregnant, have an active or past cancer, and athletes subject to drug testing.
2026 changed the rules. Here's what happened.
This year brought the biggest shift in U.S. peptide policy in a decade. It's also widely misunderstood, so here's the plain timeline.
HHS announces most restricted peptides will be reclassified
HHS announced that most peptides on the FDA's "significant safety concerns" list would be moved off it.
FDA removes 12 peptides from its restricted list
The list included BPC-157, TB-500, and injectable GHK-Cu. Important: leaving the restricted list did not by itself make them legal to compound, and it is not FDA approval.
Advisory committee votes to recommend six peptides
The FDA's compounding advisory committee recommended BPC-157, TB-500, KPV, MOTS-c, Semax, and Epitalon for the list of substances pharmacies may compound, despite FDA staff recommending against it.
The FDA's final decision
The committee's vote is advisory. If the FDA accepts it, formal rulemaking follows, which has historically taken a year or more. More peptides are scheduled for review before February 2027.
Sources: Goodwin Procter, May 2026 · AJMC, Aug 2026
How to vet a peptide seller or clinic.
Whether you're looking at a telehealth clinic or an online shop, these signs separate the careful from the careless.
Green flags
- A licensed clinician reviews your health history before anything is prescribed.
- Lab work is required at the start and repeated over time.
- The pharmacy is named and its license can be verified.
- Honest about which products are FDA-approved and which aren't.
- Clear pricing and an easy way to reach a real person.
Red flags
- "Research use only" labels on products clearly marketed for people.
- No prescription, no questionnaire, no clinician.
- Calling a compounded or unapproved peptide "FDA-approved".
- Promises of guaranteed results or "no side effects".
- No independent purity testing, or test reports that can't be verified.
Our clinic and seller rankings are coming.
Here's how we'll score them, so you can hold us to it. No company can pay to change its score, and any business relationship will be disclosed on the ranking itself.
How we check peptide news.
Every week we take viral claims and headlines about peptides, trace them back to the original study or source, and rate them on a five-point scale.
Accurate
Matches what the evidence shows.
Mostly accurate
Right overall, with small errors.
Missing context
True, but leaves out what matters.
Misleading
Uses real facts to imply something false.
False
Contradicted by the evidence.